
    
      This study is a prospective, single arm clinical trial. 45 patients enrolled in the study
      will be randomly assigned to queue1 (n=30) and queue 2 (n=15). The clinical follow-up will be
      performed in all subjects at 1 month,6 months,1 year,2 years,3 years,4 years and 5 years
      after stent implantation; angiographic,IVUS and OCT follow-up will be performed at 6 months
      and 2 years after stent implantation in queue 1; angiographic,IVUS and OCT follow-up will be
      performed at 1 year and 3 years after stent implantation in queue 2. The primary endpoint of
      the study is target lesion failure (TLF) at 30 days after stent implantation.
    
  